316 related articles for article (PubMed ID: 38187072)
1. MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives.
Chen Y; Lin T; Tang L; He L; He Y
Am J Cancer Res; 2023; 13(12):5805-5824. PubMed ID: 38187072
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma.
Wang S; Claret FX; Wu W
Front Oncol; 2019; 9():756. PubMed ID: 31456943
[TBL] [Abstract][Full Text] [Related]
3. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
4. Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.
Plieskatt JL; Rinaldi G; Feng Y; Levine PH; Easley S; Martinez E; Hashmi S; Sadeghi N; Brindley PJ; Bethony JM; Mulvenna JP
J Transl Med; 2014 Jan; 12():3. PubMed ID: 24393330
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in nasopharyngeal carcinoma.
Spence T; Bruce J; Yip KW; Liu FF
Chin Clin Oncol; 2016 Apr; 5(2):17. PubMed ID: 27121877
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review.
Lee KT; Tan JK; Lam AK; Gan SY
Crit Rev Oncol Hematol; 2016 Jul; 103():1-9. PubMed ID: 27179594
[TBL] [Abstract][Full Text] [Related]
8. TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness.
Lyu X; Fang W; Cai L; Zheng H; Ye Y; Zhang L; Li J; Peng H; Cho WC; Wang E; Marincola FM; Yao K; Cai H; Li J; Li X
Mol Cancer; 2014 Mar; 13():51. PubMed ID: 24606633
[TBL] [Abstract][Full Text] [Related]
9. The role of microRNAs in nasopharyngeal carcinoma.
Tan G; Tang X; Tang F
Tumour Biol; 2015 Jan; 36(1):69-79. PubMed ID: 25427638
[TBL] [Abstract][Full Text] [Related]
10. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.
Luo Z; Zhang L; Li Z; Li X; Li G; Yu H; Jiang C; Dai Y; Guo X; Xiang J; Li G
BMC Med Genomics; 2012 Jan; 5():3. PubMed ID: 22260379
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in nasopharyngeal carcinoma.
Bruce JP; Liu FF
Chin J Cancer; 2014 Nov; 33(11):539-44. PubMed ID: 25367334
[TBL] [Abstract][Full Text] [Related]
12. microRNA expression profiling of nasopharyngeal carcinoma.
Li T; Chen JX; Fu XP; Yang S; Zhang Z; Chen KhH; Li Y
Oncol Rep; 2011 May; 25(5):1353-63. PubMed ID: 21373758
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of differential miRNA and mRNA expression profiles in human radioresistant and radiosensitive nasopharyngeal carcinoma cells.
Li XH; Qu JQ; Yi H; Zhang PF; Yi HM; Wan XX; He QY; Ye X; Yuan L; Zhu JF; Li JY; Xiao ZQ
PLoS One; 2014; 9(1):e87767. PubMed ID: 24498188
[TBL] [Abstract][Full Text] [Related]
14. Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA-mRNA network mining and machine learning.
Zhang X; Li X; Wang C; Wang S; Zhuang Y; Liu B; Lian X
Front Endocrinol (Lausanne); 2023; 14():1174911. PubMed ID: 37538797
[TBL] [Abstract][Full Text] [Related]
15. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
16. Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers.
Zheng XH; Cui C; Ruan HL; Xue WQ; Zhang SD; Hu YZ; Zhou XX; Jia WH
Chin J Cancer; 2014 Jul; 33(7):330-8. PubMed ID: 24874644
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma.
He ML; Luo MX; Lin MC; Kung HF
Biochim Biophys Acta; 2012 Jan; 1825(1):1-10. PubMed ID: 21958739
[TBL] [Abstract][Full Text] [Related]
18. The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs.
Zhao CX; Zhu W; Ba ZQ; Xu HJ; Liu WD; Zhu B; Wang L; Song YJ; Yuan S; Ren CP
Am J Cancer Res; 2018; 8(11):2185-2209. PubMed ID: 30555738
[TBL] [Abstract][Full Text] [Related]
19. Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
Zhang Z; Huang J; Wang G; Jin F; Zheng J; Xiao H; Lei L; Luo J; Chen C
BMC Cancer; 2020 Mar; 20(1):183. PubMed ID: 32131777
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing.
Wang F; Lu J; Peng X; Wang J; Liu X; Chen X; Jiang Y; Li X; Zhang B
J Exp Clin Cancer Res; 2016 Jan; 35():17. PubMed ID: 26795575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
